Alpha Cognition Inc.
Develops and commercializes novel treatments for neurodegenerative diseases like Alzheimer's and ALS.
ACOG | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 1200-750 W PENDER ST, VANCOUVER
- Website:
- https://www.alphacognition.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Alpha Cognition Inc. is a commercial-stage biopharmaceutical company dedicated to developing and commercializing novel treatments for patients suffering from neurodegenerative diseases. The company's primary focus is on conditions such as Alzheimer's disease and amyotrophic lateral sclerosis (ALS). Its lead product is ZUNVEYL® (benzgalantamine), a cholinesterase inhibitor indicated for the treatment of mild to moderate dementia of the Alzheimer’s type.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Alpha Cognition Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Alpha Cognition Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Alpha Cognition Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
